熱門資訊> 正文
Bluejay Diagnostics通过认购权交易筹集370万美元后股价暴跌
2025-04-08 05:29
- Bluejay Diagnostics (NASDAQ:BJDX) has entered into an agreement with institutional investors to purchase shares of common stock of the company for cash.
- The investors agreed to exercise the existing warrants to purchase about 1M shares of common stock at a reduced exercise price of $3.42 per share, resulting in gross proceeds of approximately $3.7M.
- BJDX -26.66% after hours to $5.5.
- In consideration for the exercise of the existing warrants for cash, the investors received new warrants to purchase up to an aggregate of around 1M shares of common stock. The new warrants are exercisable immediately at an exercise price of $3.42 per common share and will expire five years from the issuance date.
- Source: Press Release
More on Bluejay Diagnostics
- Financial information for Bluejay Diagnostics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
